NO964721D0 - Hepatitt G virus og molekylær kloning derav - Google Patents

Hepatitt G virus og molekylær kloning derav

Info

Publication number
NO964721D0
NO964721D0 NO964721A NO964721A NO964721D0 NO 964721 D0 NO964721 D0 NO 964721D0 NO 964721 A NO964721 A NO 964721A NO 964721 A NO964721 A NO 964721A NO 964721 D0 NO964721 D0 NO 964721D0
Authority
NO
Norway
Prior art keywords
hgv
hepatitis
antigens
methods
virus
Prior art date
Application number
NO964721A
Other languages
English (en)
Other versions
NO323849B1 (no
NO964721L (no
Inventor
Jungsuh P Kim
Kirk F Fry
Lavonne Marie Young
Jeffrey M Linnen
John Wages
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of NO964721D0 publication Critical patent/NO964721D0/no
Publication of NO964721L publication Critical patent/NO964721L/no
Publication of NO323849B1 publication Critical patent/NO323849B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
NO19964721A 1994-05-20 1996-11-07 Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid. NO323849B1 (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US24698594A 1994-05-20 1994-05-20
US28554394A 1994-08-03 1994-08-03
US28555894A 1994-08-03 1994-08-03
US32972994A 1994-10-26 1994-10-26
US34427194A 1994-11-23 1994-11-23
US35750994A 1994-12-16 1994-12-16
US38988695A 1995-02-15 1995-02-15
PCT/US1995/006169 WO1995032291A2 (en) 1994-05-20 1995-05-19 Hepatitis g virus and molecular cloning thereof

Publications (3)

Publication Number Publication Date
NO964721D0 true NO964721D0 (no) 1996-11-07
NO964721L NO964721L (no) 1997-01-17
NO323849B1 NO323849B1 (no) 2007-07-09

Family

ID=27569460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964721A NO323849B1 (no) 1994-05-20 1996-11-07 Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid.

Country Status (16)

Country Link
EP (1) EP0763114B1 (no)
JP (2) JPH10503642A (no)
KR (1) KR100394693B1 (no)
CN (1) CN1125877C (no)
AT (1) ATE210185T1 (no)
CA (1) CA2190860A1 (no)
DE (1) DE69524407T2 (no)
DK (1) DK0763114T3 (no)
ES (1) ES2170152T3 (no)
FI (1) FI112249B (no)
HK (1) HK1012412A1 (no)
MX (1) MX9605666A (no)
NO (1) NO323849B1 (no)
NZ (1) NZ288000A (no)
PT (1) PT763114E (no)
WO (1) WO1995032291A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
US5709997A (en) * 1995-08-14 1998-01-20 Abbott Laboratories Nucleic acid detection of hepatitis GB virus
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
KR100247215B1 (ko) * 1995-11-21 2000-04-01 헤르베르트 포우퀘트, 만프레트 베버 신규한 non-a, non-b, non-c, non-d, non-e 간염 바이러스의 핵 산증폭 및 검출
IT1283893B1 (it) * 1996-01-24 1998-05-07 Sorin Biomedica Diagnostics Sp Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni
DE19613406A1 (de) * 1996-04-03 1997-10-09 Boehringer Mannheim Gmbh Expression von HGV-Antigenen und deren Verwendung
IT1284630B1 (it) * 1996-04-17 1998-05-21 Sorin Biomedica Diagnostics Sp Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
US5766916A (en) * 1996-04-24 1998-06-16 Genelabs Technologies, Inc. Hepatitis G virus protease
EP0832901A1 (de) * 1996-09-18 1998-04-01 Roche Diagnostics GmbH Antikörper gegen Hepatitis G-Virus und deren Verwendung zum diagnostischen Nachweis von HGV sowie als Therapeutikum
JP2001522599A (ja) * 1997-11-06 2001-11-20 イノジェネティックス・ナムローゼ・フェンノートシャップ 診断用及びワクチン用、ｃ型肝炎ウイルスエンベロープタンパク質由来マルチマーペプチド
GB0009756D0 (en) * 2000-04-19 2000-06-07 Glaxo Group Ltd Test method
WO2014097762A1 (ja) * 2012-12-20 2014-06-26 国立大学法人熊本大学 高病原性トリインフルエンザに対する抗体
US9594163B2 (en) 2013-04-15 2017-03-14 Electronics And Telecommunications Research Institute Security and surveillance system and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501203A (ja) * 1988-07-06 1992-03-05 ジェネラブズ　インコーポレイティド 後―輸血性，非―ａ，非―ｂ型肝炎ウィルス及び抗原
WO1994018217A1 (en) * 1993-02-03 1994-08-18 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO1995021922A2 (en) * 1994-02-14 1995-08-17 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use

Also Published As

Publication number Publication date
DK0763114T3 (da) 2002-04-02
KR100394693B1 (ko) 2003-12-31
MX9605666A (es) 1998-05-31
NZ288000A (en) 1998-09-24
ATE210185T1 (de) 2001-12-15
KR970703425A (ko) 1997-07-03
JP4296174B2 (ja) 2009-07-15
DE69524407T2 (de) 2002-08-01
FI964605A (fi) 1997-01-15
AU2689595A (en) 1995-12-18
JP2006115845A (ja) 2006-05-11
JPH10503642A (ja) 1998-04-07
NO323849B1 (no) 2007-07-09
NO964721L (no) 1997-01-17
DE69524407D1 (de) 2002-01-17
ES2170152T3 (es) 2002-08-01
HK1012412A1 (en) 1999-07-30
CN1125877C (zh) 2003-10-29
EP0763114B1 (en) 2001-12-05
FI964605A0 (fi) 1996-11-18
CA2190860A1 (en) 1995-11-30
WO1995032291A2 (en) 1995-11-30
AU684177B2 (en) 1997-12-04
CN1153529A (zh) 1997-07-02
WO1995032291A3 (en) 1996-03-07
EP0763114A2 (en) 1997-03-19
FI112249B (fi) 2003-11-14
PT763114E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
DK0763114T3 (da) Hepatitis G-virus og molekylær kloning deraf
ATE194844T1 (de) Hepatitis c-virus-epitope
DK480889A (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
Ohashi et al. Characterization of a new antigenic type, Kuroki, of Rickettsia tsutsugamushi isolated from a patient in Japan
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
KR940703851A (ko) E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies)
CA2057052A1 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
WO1995032292A3 (en) Detection of viral antigens coded by reverse-reading frames
CA2075366A1 (en) Immunologically active peptides or polypeptides from the parvovirus b19
AU9629498A (en) Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
ATE115964T1 (de) Non-a non-b sequenzen.
PT97428A (pt) Processo para a preparacao de epitopos do virus da hepatite c
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
KR930000127A (ko) 비(非)a 비(非)b형 간염 진단방법 및 백신

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees